Amgen(US:AMGN) Prnewswire·2025-10-29 20:01Core Viewpoint - Amgen is set to report its third quarter 2025 financial results on November 4, 2025, followed by a conference call with senior management to discuss the results and engage with the investment community [1]. Financial Results Announcement - The financial results will be announced after the close of U.S. financial markets on November 4, 2025 [1]. - A conference call will take place at 4:30 p.m. ET, featuring Robert A. Bradway, chairman and CEO, along with other senior management members [1]. Conference Call Details - The conference call will be broadcast live over the internet, accessible to media, investors, and the general public [2]. - The webcast will be archived and available for replay for at least 90 days post-event [3]. Company Overview - Amgen is a biotechnology company focused on discovering, developing, manufacturing, and delivering innovative medicines for serious diseases [4]. - The company has a strong pipeline aimed at treating various conditions, including cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases [4]. Recognition and Market Position - In 2024, Amgen was recognized as one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes [5]. - Amgen is part of the Dow Jones Industrial Average and the Nasdaq-100 Index, highlighting its significant market presence [5].